Teresa Gagliano

TENURE-TRACK ASSISTANT PROFESSOR

Università degli Studi di Udine

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Cancer Biology Cancer Biology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Teresa Gagliano is a Tenure-Track Assistant Professor at Università degli Studi di Udine in Italy. Her research primarily focuses on neuroendocrine tumors, cancer gene therapy, and the role of epigenetic mechanisms in tumor development and treatment. Recent publications include studies on tumor microenvironments, histone deacetylase inhibitors, and the chromatin landscape in cancer therapies.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Mark Roe

University of Sussex

UNITED KINGDOM

View details

Claudio BRANCOLINI

Full professor

Università degli Studi di Udine

ITALY

View details

Georgios Giamas

Professor of Cancer Cell Signalling

University of Sussex

UNITED KINGDOM

View details

Murat Eravci

University of Sussex

UNITED KINGDOM

View details

Angeliki Ditsiou

University of Sussex

UNITED KINGDOM

View details

Luigi Formisano

ITALY

View details

Emiliano Dalla

Università degli Studi di Udine

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Teresa Gagliano

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

FAK inhibition disrupts tumor growth, apoptosis, and transcriptional regulation in GI-NETs

Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids

Exploring Emerging Therapeutic Targets and Opportunities in Neuroendocrine Tumors: Updates on Receptor Tyrosine Kinases

Kinome-Wide Synthetic Lethal Screen Identifies PANK4 as a Modulator of Temozolomide Resistance in Glioblastoma.

Decoding the Tumour Microenvironment: Molecular Players, Pathways, and Therapeutic Targets in Cancer Treatment

Estrogen receptor status heterogeneity in breast cancer tumor: role in response to endocrine treatment

Cancer gene therapy 2020: highlights from a challenging year

Targeting histone deacetylases for combination therapies in neuroendocrine tumors

Epigenetic Mechanisms beyond Tumour–Stroma Crosstalk

Quis Custodiet Ipsos Custodes (Who Controls the Controllers)? Two Decades of Studies on HDAC9

Correction to: LMTK3 inhibition affects microtubule Stability (Molecular Cancer, (2021), 20, 1, (53), 10.1186/s12943-021-01345-3)

LMTK3 inhibition affects microtubule stability

The multifaceted role of lemur tyrosine kinase 3 in health and disease

The structure-function relationship of oncogenic LMTK3.

Androgen receptor signaling regulates the transcriptome of prostate cancer cells by modulating global alternative splicing

Collaborators (7)

Mark Roe

Claudio BRANCOLINI

Georgios Giamas

Murat Eravci

Angeliki Ditsiou

Luigi Formisano

Emiliano Dalla

Make your next move.